Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
NeoImmuneTech
DualityBio Inc.
Tanabe Pharma America, Inc.
CRISPR Therapeutics
Marengo Therapeutics, Inc.
Numab Therapeutics AG
Cancer Research UK
Elucida Oncology
Evopoint Biosciences Inc.
Centre Leon Berard
Kineta Inc.
Genelux Corporation
Radboud University Medical Center
University Health Network, Toronto